TABLE 2.
Stages were introduced as covariates to obtain significant prognostic genes.
| Genes | p-value | HR | Low 95%CI | High 95%CI | Entrezid | Symbol |
| ENSG00000138755 | 0.00849 | 0.995426 | 0.992033 | 0.99883 | 4,283 | CXCL9 |
| ENSG00000010030 | 0.04061 | 0.981223 | 0.963579 | 0.99919 | 51,513 | ETV7 |
| ENSG00000162654 | 0.022077 | 0.992104 | 0.985392 | 0.998861 | 115,361 | GBP4 |
| ENSG00000211772 | 0.02085 | 0.987918 | 0.977784 | 0.998157 | 28638 | TRBC2 |
| ENSG00000225492 | 0.00091 | 0.962018 | 0.940256 | 0.984283 | 400,759 | GBP1P1 |
| ENSG00000198851 | 0.048451 | 0.983727 | 0.967827 | 0.999888 | 916 | CD3E |
| ENSG00000256262 | 0.026533 | 0.956429 | 0.919515 | 0.994825 | 100,131,733 | USP30-AS1 |
| ENSG00000211753 | 0.013667 | 0.977354 | 0.959721 | 0.995311 | 28,559 | TRBV28 |
| ENSG00000168394 | 0.005226 | 0.996155 | 0.993465 | 0.998852 | 6,890 | TAP1 |
| ENSG00000240065 | 0.009633 | 0.996091 | 0.993141 | 0.999049 | 5,698 | PSMB9 |